Drug Type Small molecule drug |
Synonyms CPT 31, CPT31-LA |
Target |
Mechanism gp41 inhibitors(Transmembrane glycoprotein gp41 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Navigen, Inc.Startup |
Active Organization- |
Inactive Organization Navigen, Inc.Startup |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Phase 1 | US | Navigen, Inc.Startup | 16 Nov 2020 |
Phase 1 | 32 | (Cohort 1 0.01 mg/kg CPT31) | esndycwtyp(sofuemezoc) = lymtjrhdej bznbrmvogn (fgapzyxsjq, kcammeoswv - ibeeeeioty) View more | - | 21 Feb 2023 | ||
(Cohort 2 0.04 mg/kg CPT31) | esndycwtyp(sofuemezoc) = mdfzkstbeo bznbrmvogn (fgapzyxsjq, scicmhrkuv - fimcjjutvw) View more |